¼¼°èÀÇ ÁÖÀÔ ÆßÇÁ ½ÃÀå : Á¦Ç°º°, Åõ¿© ¸ðµåº°, ÃÖÁ¾»ç¿ëÀÚº°, ¿ëµµº°, Áö¿ªº° - ¿¹Ãø(-2030³â)
Infusion Pump Market by Product(Accessories(Dedicated, Non-dedicated), Devices (Insulin, Syringe, Volumetric, Enteral, PCA Pump)), Technology(Traditional, Specialty), Mode(Stationary, Portable), Application(Cancer, Diabetes) - Global Forecast to 2030
»óǰÄÚµå : 1756516
¸®¼­Ä¡»ç : MarketsandMarkets
¹ßÇàÀÏ : 2025³â 06¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 583 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,950 £Ü 6,777,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,650 £Ü 9,104,000
PDF (5-user License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,150 £Ü 11,158,000
PDF (Corporate License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÀÌ¿ë Àοø¿¡ Á¦ÇÑÀº ¾øÀ¸³ª, ±¹³»¿¡ ÀÖ´Â »ç¾÷À常 ÇØ´çµÇ¸ç, ÇØ¿Ü ÁöÁ¡ µîÀº Æ÷ÇÔµÇÁö ¾Ê½À´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 10,000 £Ü 13,691,000
PDF (Global License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. (100% ÀÚȸ»ç´Â µ¿ÀÏ ±â¾÷À¸·Î °£Áֵ˴ϴÙ.) Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

ÁÖÀÔ ÆßÇÁ ½ÃÀå ±Ô¸ð´Â 7.4%ÀÇ CAGR·Î È®´ëµÇ¾î 2025³â 198¾ï 6,350¸¸ ´Þ·¯¿¡¼­ 2030³â¿¡´Â 283¾ï 4,500¸¸ ´Þ·¯·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

´ç´¢º´, ¾Ï, ½ÉÇ÷°üÁúȯ°ú °°Àº ¸¸¼ºÁúȯÀÇ À¯º´·ü Áõ°¡·Î ÀÎÇØ ¾à¸® ¿ä¹ýÀÇ Á¤È®Çϰí ÅëÁ¦µÈ Áö¼ÓÀûÀÎ Åõ¿©°¡ ÇÊ¿äÇϸç, ÀÌ´Â ¼ö¾× ÆßÇÁ ±â¼úÀÇ ½ÃÀå ¼ºÀåÀ» Å©°Ô ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ±â±â °øÇÐÀÇ ¹ßÀüÀº ¹«¼± ¿¬°á ¹× Åõ¾à ¿À·ù °¨¼Ò ¾Ë°í¸®ÁòÀ» °®Ãá ½º¸¶Æ® ¼ö¾× ½Ã½ºÅÛÀÇ ÁøÈ­¸¦ ÃËÁøÇÏ¿© ȯÀÚÀÇ ¾ÈÀü¼ºÀ» ³ôÀÌ°í ¾à¹° Åõ¿©ÀÇ È¿À²¼ºÀ» Çâ»ó½Ã۰í ÀÖ½À´Ï´Ù. ÀüÅëÀûÀÎ ÀÔ¿ø ȯ°æ°ú ´Þ¸® ÀçÅÃÀÇ·á ¼Ö·ç¼ÇÀ¸·ÎÀÇ ÀüȯÀº ÀÌ·¯ÇÑ Ã·´Ü Àü´Þ ½Ã½ºÅÛ¿¡ ´ëÇÑ ´õ ¸¹Àº ¼ö¿ä¸¦ âÃâÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¼ö¾× ÆßÇÁ¸¦ µÑ·¯½Ñ ¾ö°ÝÇÑ ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©¿Í °­È­µÈ »çÀ̹ö º¸¾È ÇÁ·ÎÅäÄÝÀº º¸´Ù ¾ÈÀüÇÏ°í ½Å·ÚÇÒ ¼ö ÀÖ´Â ½Ã½ºÅÛ °³¹ßÀ» ÃËÁøÇÏ¿© ½ÃÀå È®´ë¸¦ ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

Á¶»ç ¹üÀ§
Á¶»ç ´ë»ó ¿¬µµ 2024-2030³â
±âÁØ ¿¬µµ 2024³â
¿¹Ãø ±â°£ 2024-2030³â
°ËÅä ´ÜÀ§ ±Ý¾×(10¾ï ´Þ·¯)
ºÎ¹®º° Á¦Ç°º°, Åõ¿© ¸ðµåº°, ÃÖÁ¾»ç¿ëÀÚº°, ¿ëµµº°, Áö¿ªº°
´ë»ó Áö¿ª ºÏ¹Ì, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¤¸ÆÁÖ»ç(IV) ºÎ¹®Àº ÀǾàǰ ½ÃÀåÀÇ ÁÖ¿ä ¼ºÀå ºÐ¾ß·Î ºü¸£°Ô ºÎ»óÇϰí ÀÖÀ¸¸ç, ƯÈ÷ ±Þ¼º±â ÀÇ·á ¹× ÀÀ±ÞÀÇ·á ȯ°æ¿¡¼­ ½Å¼ÓÇϰí Á¤È®ÇÑ ¾à¹° Åõ¿©¿¡ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí Àֱ⠶§¹®ÀÔ´Ï´Ù. Á¤¸ÆÅõ¿©´Â »ýü ÀÌ¿ë·ü(»ýü ÀÌ¿ë·ü)À» Çâ»ó½Ã۱⠶§¹®¿¡ ¼ö¼úÀ̳ª ±Þ¼º±â ÀÇ·á µî Áï°¢ÀûÀÎ È¿°ú°¡ ¿ä±¸µÇ´Â Ä¡·á¿¡´Â ÇʼöÀûÀÎ ¿ä¼ÒÀÔ´Ï´Ù. ¸¸¼ºÁúȯ, ƯÈ÷ Ç×¾ÏÁ¦ Á¤¸ÆÅõ¿©°¡ ÇÊ¿äÇÑ ¾ÏÀÇ ¹ßº´·ü Áõ°¡´Â ÀÌ ½ÃÀåÀÇ ¼ºÀåÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Åõ¾à ¿À·ù °¨¼Ò ½Ã½ºÅÛÀ» °®Ãá ½º¸¶Æ® ÁÖÀÔ ÆßÇÁ¿Í °°Àº ±â¼úÀÇ ¹ßÀüÀ¸·Î ¾à¹°Àü´ÞÀÇ ¾ÈÀü¼º°ú È¿À²¼ºÀÌ Å©°Ô Çâ»óµÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼ú Çõ½ÅÀº ¾ö°ÝÇÑ ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©¿Í °­È­µÈ »çÀ̹ö º¸¾È Á¶Ä¡¿Í ÇÔ²² Á¤¸Æ ³» Ä¡·á¿¡ ´ëÇÑ È¯ÀÚµéÀÇ ¼øÀÀµµ¸¦ ³ôÀÌ´Â µ¥ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼úÀû Áøº¸, ÃÖÀûÈ­µÈ Àü´Þ ½Ã½ºÅÛ, Ç¥ÁØÈ­µÈ ÀÓ»ó °üÇàÀÇ °áÇÕÀ¸·Î ¼ö¾× Åõ¿©´Â ÇコÄÉ¾î ºÐ¾ß¿¡¼­ °¡Àå ºü¸£°Ô ¼ºÀåÇÏ´Â ºÐ¾ß·Î ÀÚ¸®¸Å±èÇϰí ÀÖ½À´Ï´Ù.

Á¾¾çÇÐ/È­Çпä¹ý ºÎ¹®Àº ¼ö¾× ÆßÇÁ ¾÷°è¿¡¼­ ¾ÐµµÀûÀÎ ½ÃÀå Á¡À¯À²À» Â÷ÁöÇϰí ÀÖÀ¸¸ç, ÀÌ´Â Àü ¼¼°èÀûÀ¸·Î ¾Ï ¹ß»ý·üÀÌ Áõ°¡Çϰí È¿°úÀûÀÎ Ä¡·á¸¦ À§ÇØ Áö¼ÓÀûÀÎ ¾à¹° Åõ¿©°¡ ÇÊ¿äÇϱ⠶§¹®ÀÔ´Ï´Ù. ¼¼°èº¸°Ç±â±¸(WHO)¿¡ µû¸£¸é 2022³â¿¡ »õ·Î ¹ß»ýÇÑ ¾Ï ȯÀÚ´Â 2,000¸¸ ¸í, 2050³â¿¡´Â 3,500¸¸ ¸í¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøÇϰí ÀÖ½À´Ï´Ù. ¼ö¾× ÆßÇÁ´Â È­Çпä¹ýÁ¦ Àü´Þ¿¡ ÇʼöÀûÀ̸ç, µ¶¼ºÀ» ÃÖ¼ÒÈ­Çϸ鼭 Ä¡·á È¿°ú¸¦ ³ôÀÌ´Â Á¤È®Çϰí ÅëÁ¦µÈ ¾à¹° Åõ¿©¸¦ ½ÇÇöÇÕ´Ï´Ù. ÈÞ´ë¿ë ¹× À̽ÄÇü ¼ö¾× ÆßÇÁÀÇ µîÀåÀ¸·Î È­Çпä¹ýÀº ÀçÅà ġ·á ȯ°æÀ¸·Î ¿Å°Ü°¡°í ÀÖÀ¸¸ç, ÀÌ´Â ÀÌ ºÐ¾ßÀÇ È®ÀåÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¹«¼± ¿¬°á ¹× ÀüÀÚ ÀÇ·á ±â·Ï(EMR)°úÀÇ ÅëÇÕÀ» Ư¡À¸·Î ÇÏ´Â ½º¸¶Æ® ¼ö¾× ÆßÇÁ¿Í °°Àº ¼ö¾× ±â¼úÀÇ ¹ßÀüÀº ½ÃÀå ¼ºÀåÀ» Å©°Ô ÃËÁøÇÏ°í ´õ ³ªÀº ȯÀÚ °ü¸®¸¦ ¿ëÀÌÇÏ°Ô Çϰí ÀÖ½À´Ï´Ù.

¾Æ½Ã¾ÆÅÂÆò¾çÀº ¼ö¾× ÆßÇÁ ½ÃÀå¿¡¼­ °¡Àå ºü¸£°Ô ¼ºÀåÇÏ´Â Áö¿ªÀ¸·Î ºÎ»óÇϰí ÀÖÀ¸¸ç, ±× ÁÖ¿ä ÀÌÀ¯´Â Àα¸Åë°èÇÐÀû º¯È­, ¸¸¼ºÁúȯÀÇ À¯º´·ü Áõ°¡, ÀÇ·á ÀÎÇÁ¶óÀÇ ¹ßÀü¿¡ ±âÀÎÇÕ´Ï´Ù. Áß±¹, Àεµ, ÀϺ» µîÀÇ ±¹°¡¿¡¼­´Â ´ç´¢º´, ¾Ï, ½ÉÇ÷°üÁúȯ µî ¸¸¼ºÁúȯÀÌ ±ÞÁõÇϰí ÀÖÀ¸¸ç, ¼ö¾×ÆßÇÁ¿Í °°Àº Áö¼ÓÀû Åõ¾à ½Ã½ºÅÛÀÇ µµÀÔÀÌ ¿ä±¸µÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¼ö¿ä´Â ÀϹÝÀûÀ¸·Î º¹ÀâÇϰí Àå±âÀûÀÎ Ä¡·á°¡ ÇÊ¿äÇÑ ³ëÀÎ Àα¸ÀÇ Áõ°¡·Î ÀÎÇØ ´õ¿í ¾ÇÈ­µÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Áö¿ª Á¤ºÎ´Â ÇコÄɾ ´ëÇÑ ÅõÀÚ¸¦ È®´ëÇϰí ÀÎÇÁ¶ó¸¦ °­È­ÇÏ¿© ÷´Ü ÀÇ·á ±â¼ú¿¡ ´ëÇÑ Á¢±Ù¼ºÀ» °³¼±ÇÏ°í ½ÃÀå ¼ºÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ±â¼ú ¹ßÀü, ƯÈ÷ ½º¸¶Æ® ÁÖÀÔ ÆßÇÁÀÇ °³¹ßµµ ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ½ÃÀå ¿ªÇÐÀ» ÃËÁøÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼ú Çõ½ÅÀº ¾à¹°Àü´ÞÀÇ Á¤È®¼ºÀ» Çâ»ó½Ãų »Ó¸¸ ¾Æ´Ï¶ó ȯÀÚ ¸ð´ÏÅ͸µ ¹× °ü¸®¸¦ °³¼±ÇÏ¿© ÀÌ Áö¿ª ÀÇ·á ½Ã½ºÅÛÀÇ ÁøÈ­ÇÏ´Â ¿ä±¸¿¡ ºÎÀÀÇϰí ÀÖ½À´Ï´Ù.

º» º¸°í¼­¿¡¼­´Â ÁÖÀÔ ÆßÇÁ ½ÃÀåÀ» À¯Çü, Åõ¿© ¹æ¹ý, ¿ëµµ, ÃÖÁ¾»ç¿ëÀÚ, Áö¿ªº°·Î Á¶»çÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ½ÃÀå ¼ºÀå¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ¿äÀÎ(½ÃÀå ÃËÁø¿äÀÎ ¹× °úÁ¦)¿¡ ´ëÇØ¼­µµ Á¶»çÇÏ¿´½À´Ï´Ù. ½ÃÀåÀÇ ±âȸ¿Í °úÁ¦¸¦ ºÐ¼®Çϰí, ½ÃÀå ¸®´õÀÇ °æÀï »óȲ¿¡ ´ëÇÑ ÀÚ¼¼ÇÑ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù. ¶ÇÇÑ, °³º° ¼ºÀå µ¿Çâ°ú °ü·ÃÇÏ¿© ¸¶ÀÌÅ©·Î ½ÃÀåÀ» ºÐ¼®Çϰí, ÁÖ¿ä 6°³ Áö¿ª°ú °¢ ±¹°¡º° ½ÃÀå ºÎ¹®ÀÇ ¼öÀÍÀ» ¿¹ÃøÇϰí ÀÖ½À´Ï´Ù.

º¸°í¼­ ±¸¸Å ÀÌÀ¯

ÀÌ º¸°í¼­´Â ±âÁ¸ ±â¾÷À̳ª ½Å±Ô ¶Ç´Â ¼Ò±Ô¸ð ±â¾÷ÀÌ ½ÃÀå µ¿ÇâÀ» ÀÌÇØÇÏ°í ´õ Å« ½ÃÀå Á¡À¯À²À» È®º¸ÇÏ´Â µ¥ µµ¿òÀÌ µÉ °ÍÀÔ´Ï´Ù. º» º¸°í¼­¸¦ ±¸¸ÅÇÑ ±â¾÷Àº ´ÙÀ½ 5°¡Áö Àü·« Áß Çϳª ÀÌ»óÀ» Ȱ¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼Ò°³

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ÁÖ¿ä ÀλçÀÌÆ®

Á¦5Àå ½ÃÀå °³¿ä

Á¦6Àå ÁÖÀÔ ÆßÇÁ ½ÃÀå(Á¦Ç°º°)

Á¦7Àå ÁÖÀÔ ÆßÇÁ ½ÃÀå(Åõ¿© ¸ðµåº°)

Á¦8Àå ÁÖÀÔ ÆßÇÁ ½ÃÀå(ÃÖÁ¾»ç¿ëÀÚº°)

Á¦9Àå ÁÖÀÔ ÆßÇÁ ½ÃÀå(¿ëµµº°)

Á¦10Àå ÁÖÀÔ ÆßÇÁ ½ÃÀå(Áö¿ªº°)

Á¦11Àå °æÀï ±¸µµ

Á¦12Àå ±â¾÷ °³¿ä

Á¦13Àå ºÎ·Ï

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The infusion pump market is projected to grow from USD 19,863.5 million in 2025 to USD 28,345 million by 2030, at a CAGR of 7.4%. The increasing incidence of chronic diseases such as diabetes, cancer, and cardiovascular disorders necessitates the precise, controlled, and continuous delivery of pharmacological therapies, significantly propelling market growth for infusion pump technologies. Furthermore, advancements in device engineering have catalyzed the evolution of smart infusion systems equipped with wireless connectivity and dose-error reduction algorithms, thereby enhancing patient safety and improving the efficiency of drug administration. The shift towards home-based healthcare solutions, in contrast to traditional inpatient settings, is creating additional demand for these advanced delivery systems. Moreover, stringent regulatory frameworks and enhanced cybersecurity protocols surrounding infusion pumps are fostering the development of safer, more reliable systems, further reinforcing market expansion.

Scope of the Report
Years Considered for the Study2024-2030
Base Year2024
Forecast Period2024-2030
Units ConsideredValue (USD billion)
SegmentsBy Mode of Administration, Application, End User, Region
Regions coveredNorth America, Europe, Asia Pacific, Latin America, and Middle East & Africa

"By mode of administration, the intravenous mode of administration segment is projected to grow at the highest CAGR during the forecast period."

The intravenous (IV) mode of administration segment is rapidly emerging as the leading growth area in the pharmaceutical market, primarily due to its critical role in the rapid and precise delivery of medications, particularly within acute and emergency care environments. IV administration provides enhanced bioavailability, a crucial factor for therapies necessitating immediate therapeutic effects, such as during surgical procedures or acute medical situations. The rising incidence of chronic conditions, notably cancer, which often necessitates the intravenous administration of chemotherapeutic agents, further propels the expansion of this market. Additionally, advancements in technology, such as smart infusion pumps equipped with dose-error reduction systems, have significantly improved the safety and efficiency of IV drug delivery. These innovations, combined with stringent regulatory frameworks and reinforced cybersecurity measures, have led to heightened patient compliance with IV therapies. The convergence of these technological advancements, optimized delivery systems, and standardized clinical practices solidifies IV administration's position as the fastest-growing segment within the healthcare field.

"By application, the chemotherapy/oncology segment accounted for the largest market share in 2024."

The oncology/chemotherapy segment represents the predominant market share within the infusion pump industry, largely attributed to the escalating incidence of cancer globally, which necessitates ongoing drug administration for effective treatment. According to the World Health Organization (WHO), cancer accounted for 20 million new cases in 2022, with projections estimating 35 million cases by 2050. Infusion pumps are critical for the delivery of chemotherapy agents, providing precise and controlled drug administration that enhances therapeutic efficacy while minimizing toxicity. The advent of portable and implantable infusion pumps has transitioned chemotherapy into home care environments, further driving the expansion of this segment. Moreover, advancements in infusion technology, such as smart infusion pumps featuring wireless connectivity and integration with electronic medical records (EMRs), have significantly propelled market growth and facilitated better patient management.

"The Asia Pacific region is expected to witness the highest growth rate during the forecast period."

The Asia-Pacific region is emerging as the fastest-growing sector in the infusion pump market, largely due to significant demographic shifts, a rising incidence of chronic diseases, and advancements in healthcare infrastructure. Countries such as China, India, and Japan are witnessing an upsurge in chronic conditions-diabetes, cancer, and cardiovascular diseases-necessitating the implementation of continuous medication delivery systems like infusion pumps. This demand is exacerbated by the increasing geriatric population, which typically requires complex and long-term medical treatments. Moreover, regional governments are instrumental in bolstering market growth by amplifying investments in healthcare and enhancing infrastructure, thereby improving access to advanced medical technologies. Technological advancements, particularly the development of smart infusion pumps, are also playing a pivotal role in propelling market dynamics within the Asia-Pacific region. These innovations not only improve medication delivery precision but also allow for better patient monitoring and management, aligning with the evolving needs of healthcare systems in the region.

Breakdown of supply-side primary interviews: * By Company Type: Tier 1 (45%), Tier 2 (20%), and Tier 3 (35%) * By Designation: C-level Executives (35%), Directors (25%), and Other Designations (40%) * By Region: North America (40%), Europe (25%), Asia Pacific (20%), Latin America (10%), and Middle East & Africa (5%)

Breakdown of demand-side primary interviews: * By Company Type: Hospitals (38%), Home Care Settings (25%), Ambulatory Care Settings (20%), Academic & Research Institutes (12%), Oncology Centers (3%), Other End Users (2%) * By Designation: Healthcare Professionals (35%), Department Heads (27%), Procurement Heads (22%), and Other Designations (16%) * By Region: North America (40%), Europe (25%), Asia Pacific (20%), Latin America (10%), and Middle East & Africa (5%)

Research Coverage

This report studies the infusion pump market based on type, mode of administration, application, end user, and region. It also studies factors affecting market growth (drivers, restraints, opportunities, and challenges). It analyzes the market's opportunities and challenges and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to six main regions and respective countries.

Reasons to Buy the Report

The report can help established companies, and new or smaller firms understand market trends, which will help them capture a larger market share. Firms that purchase the report can utilize one or more of the five strategies mentioned below.

This report provides insights into the following points:

TABLE OF CONTENTS

1 INTRODUCTION

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

5 MARKET OVERVIEW

6 INFUSION PUMPS MARKET, BY PRODUCT

7 INFUSION PUMPS MARKET, BY MODE OF ADMINISTRATION

8 INFUSION PUMPS MARKET, BY END USER

9 INFUSION PUMPS MARKET, BY APPLICATION

10 INFUSION PUMPS MARKET, BY REGION

11 COMPETITIVE LANDSCAPE

12 COMPANY PROFILES

13 APPENDIX

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â